Internet-based Cognitive Behavioral Therapy for Individuals With Gambling Disorder in Indonesia (ICBT)

July 10, 2024 updated by: Kristiana Siste, Indonesia University

Internet-based Cognitive Behavioral Therapy for Individuals With Gambling Disorder in Indonesia: a Pilot and Feasibility Study

Gambling disorder (GD) has become a wide concern in Indonesia, as many negative consequences aroused from this psychiatric condition. Prompt treatment with appropriate method of delivery is required to achieve optimal outcome in GD patients. This study aims to determine the effectiveness and feasibility of internet-based cognitive behavioral therapy (iCBT) in treating GD.

This non-randomised pilot and feasibility study will recruit 20 people with GD. All participants will receive the iCBT intervention through self-learning videos and guided weekly group sessions. The effectiveness of the intervention will be assessed at baseline (week 0), post-treatment completion (week 10), and 6 weeks post-treatment (week 16).

Expanded access of the iCBT module will not be available until after the study completion.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • be aged 18-59 years old;
  • be screened as probable pathological gambler based on South Oaks Gambling Screen (SOGS);
  • have access to electronic devices (ie, smartphone, mobile tablet, personal computer) with internet connection;
  • be proficient in Indonesian language;
  • have agreed to take part in the study by filling out the informed consent form.

Exclusion Criteria:

  • have severe mental disorders or intellectual disabilities;
  • have extreme agitation that hinder instrument fill out and adequate cognitive behavior therapy participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Internet-based Cognitive Behavioral Therapy
10 guided therapy sessions (once-weekly) with each session lasting 20 minutes.
All participants will undergo 10 guided therapy sessions (once-weekly) with each session lasting 20 minutes. The therapy module will be given as an online self-learning source via videos in a website specifically developed for this training. The videos will divide the module content into several parts with each video lasting about 10 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gambling symptom severity
Time Frame: G-SAS will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)
a decrease in Gambling Symptom Assessment Scale (G-SAS) score
G-SAS will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)
Problem gambling severity
Time Frame: PGSI will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)
a decrease in Problem Gambling Severity Index score
PGSI will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)
Gambling urges
Time Frame: GUS will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)
a decrease in Gambling Urge Scale (GUS) score
GUS will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)
Gambling-related cognitive distortions
Time Frame: GRCS will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)
a decrease in Gambling Related Cognitions Scale (GRCS) score
GRCS will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nonspecific psychological distress
Time Frame: SRQ-20 will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)
a decrease in Self Rating Questionnaire-20 (SRQ-20) score
SRQ-20 will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)
Subjective quality of life
Time Frame: WHOQOL-BREF will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)
an increase in World Health Organization Quality-of-Life Scale (WHOQOL-BREF) score
WHOQOL-BREF will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2024

Primary Completion (Estimated)

November 1, 2024

Study Completion (Estimated)

January 1, 2025

Study Registration Dates

First Submitted

December 6, 2023

First Submitted That Met QC Criteria

December 6, 2023

First Posted (Actual)

December 14, 2023

Study Record Updates

Last Update Posted (Actual)

July 11, 2024

Last Update Submitted That Met QC Criteria

July 10, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • KET-992-2023

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gambling

Clinical Trials on iCBT

Subscribe